Magnetic Resonance Imaging Predictors of Treatment Response in Late-Life Depression
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
In older adults, depression not only results in more years lived with disability than any other disease but it also carries additional risks of suicide, medical comorbidities, and family caregiving burden. Because it can take many months to identify an effective treatment regimen, it is of utmost importance to shorten the window of time and identify early on what medications and dosages will work effectively for individuals having depression. Late-life depression (LLD) has been associated with greater burden of age-related changes (eg, atrophy, white matter ischemic changes, and functional connectivity). Depression in midlife has been shown to alter affective reactivity and regulation, and functional magnetic resonance imaging (fMRI) studies in LLD have replicated the same abnormalities. Effective treatment can normalize these alterations. This article provides a review of the current literature using structural and functional neuroimaging to identify MRI predictors of treatment response in LLD. The majority of the literature on structural MRI has focused on the vascular depression hypothesis, and studies support the view that loss of brain volume and white matter integrity was associated with poorer treatment outcomes. Studies using fMRI have reported that lower task-based activity in the prefrontal cortex and limbic regions was associated with poorer outcome. These imaging markers may be integrated into clinical decision making to attain better treatment outcomes in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jack, C. R., Albert, M. S., Knopman, D. S., McKhann, G. M., Sperling, R. A., Carrillo, M. C., Thies, B., & Phelps, C. H. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.004 · Cited by 2,042 · cited 1×
“Specifically, MRI-quantified medial temporal lobe atrophy, fludeoxyglucose–positron emission tomographic (PET), and PET amyloid imaging were deemed appropriate to assess for the presence of AD pathophysiological processes that help stratify patients within preclinical AD, mild cognitive impairment due to AD, and demen…”
MethodNeurobiology of emotion perception II: implications for major psychiatric disorders
Phillips, M. L., Drevets, W. C., Rauch, S. L., & Lane, R. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00171-9 · Cited by 1,736
Knopman, D. S., DeKosky, S. T., Cummings, J. L., Chui, H., Corey–Bloom, J., Relkin, N., Small, G. W., Miller, B., & Stevens, J. C. (2001) · Neurology · doi:10.1212/wnl.56.9.1143 · Cited by 1,410
Sheline, Y. I., Barch, D. M., Donnelly, J. M., Ollinger, J. M., Snyder, A. Z., & Mintun, M. A. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01263-x · Cited by 1,191 · cited 1×
“Several studies have examined the demographic, clinical, cognitive, imaging, and physiologic predictors of treatment response.(1-6,9-16) The current review provides an update focused on the use of magnetic resonance imaging (MRI) predictors of treatment response in geriatric depression.”
BackgroundPractice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder
(2008) · APA Practice Guidelines for the Treatment of Psychiatric Disorders: Comprehensive Guidelines and Guideline Watches · doi:10.1176/appi.books.9780890423363.149114 · Cited by 1,028
Toward a Neuroimaging Treatment Selection Biomarker for Major Depressive Disorder
McGrath, C. L., Kelley, M. E., Holtzheimer, P. E., Dunlop, B. W., Craighead, W. E., Franco, A. R., Craddock, R. C., & Mayberg, H. S. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.143 · Cited by 561
Clinically defined vascular depression
(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.4.562 · Cited by 557
Harmer, C. J., Goodwin, G. M., & Cowen, P. J. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.108.051193 · Cited by 542
Maintenance Treatment of Major Depression in Old Age
Reynolds, C. F., Dew, M. A., Pollock, B. G., Mulsant, B. H., Frank, E., Miller, M. D., Houck, P. R., Mazumdar, S., Butters, M. A., Stack, J. A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052619 · Cited by 476 · cited 8×
“This article provides a review of the current literature using structural and functional neuroimaging to identify MRI predictors of treatment response in LLD.”
BackgroundInfluentialAlexopoulos, G. S., Hoptman, M. J., Kanellopoulos, D., Murphy, C. F., Lim, K. O., & Gunning, F. M. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.12.002 · Cited by 437
Cited by
Vascular depression consensus report – a critical update
Aizenstein, H. J., Baskys, A., Boldrini, M., Butters, M. A., Diniz, B. S., Jaiswal, M. K., Jellinger, K. A., Kruglov, L. S., Meshandin, I. A., Mijajlovic, M. D., et al. (2016) · BMC Medicine · doi:10.1186/s12916-016-0720-5 · Cited by 258
Self-citationMarwood, L., Wise, T., Perkins, A. M., & Cleare, A. J. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.09.022 · Cited by 251
Karim, H. T., Andreescu, C., Tudorascu, D., Smagula, S. F., Butters, M. A., Karp, J. F., Reynolds, C., & Aizenstein, H. J. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.55 · Cited by 95
Self-citationMRI predictors of pharmacotherapy response in major depressive disorder
Gerlach, A. R., Karim, H. T., Peciña, M., Ajilore, O., Taylor, W. D., Butters, M. A., & Andreescu, C. (2022) · NeuroImage: Clinical · doi:10.1016/j.nicl.2022.103157 · Cited by 57
Self-citationLangenecker, S. A., Klumpp, H., Peters, A. T., Crane, N. A., DelDonno, S. R., Bessette, K. L., Ajilore, O., Leow, A., Shankman, S. A., Walker, S. J., et al. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.07.001 · Cited by 11
Self-citation
Metadata
- Authors
- Aizenstein, H. J., Khalaf, A., Walker, S. E., & Andreescu, C.
- Venue
- Journal of Geriatric Psychiatry and Neurology
- Publisher
- SAGE Publications
- Published
- 2013-12-30
- Volume
- 27
- Issue
- 1
- Pages
- 24-32
- ISSN
- 0891-9887 (ISSN-L)
- 1552-5708
- OpenAlex
- W2119452022
- Cited by
- 53
- References
- 22
- FWCI
- 4.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Magnetic Resonance Imaging Predictors of Treatment Response in Late-Life Depression. https://app.cochat.ai/papers/10.1177/0891988713516541
- The paper
- Aizenstein, H. J., Khalaf, A., Walker, S. E., & Andreescu, C. (2014). Magnetic Resonance Imaging Predictors of Treatment Response in Late-Life Depression. Journal of Geriatric Psychiatry and Neurology. https://doi.org/10.1177/0891988713516541
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.